Advertisement

Most Recent

image: Setback for Malaria Vaccine

Setback for Malaria Vaccine

By | November 9, 2012

The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.

0 Comments

image: Epigenetics Armed German E. coli

Epigenetics Armed German E. coli

By | November 9, 2012

The 2011 outbreak in Germany that caused some 50 deaths was caused by a strain of E. coli with a complex mechanism of gene regulation.

3 Comments

image: How Mole Rats Fight Cancer

How Mole Rats Fight Cancer

By | November 6, 2012

Blind mole rats resist cancer by killing cells that proliferate in a similar way to tumor cells.

0 Comments

image: The Brain on Anesthetics

The Brain on Anesthetics

By | November 5, 2012

Recording brain activity as patients are anesthetized for surgery, researchers identify a pattern that may signal loss of consciousness.  

1 Comment

image: Gingers More Prone to Skin Cancer

Gingers More Prone to Skin Cancer

By | November 2, 2012

Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.

5 Comments

image: A Guide to the Epigenome

A Guide to the Epigenome

By | November 1, 2012

Making sense of the data deluge

0 Comments

image: Contributors

Contributors

By | November 1, 2012

Meet some of the people featured in the November 2012 issue of The Scientist.

0 Comments

image: Omega-3s: Fishing for a Mechanism

Omega-3s: Fishing for a Mechanism

By | November 1, 2012

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.

4 Comments

image: The Road Less Traveled

The Road Less Traveled

By | November 1, 2012

First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.

1 Comment

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Panasonic
Panasonic

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies